Cole Pinnow serves as Executive at Cogent Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Cole Pinnow has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 17, 2025 involved receiving (via award) 50,000 shares valued at $0.
Cole Pinnow currently holds 97,450 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cole Pinnow has been a net neutral trader of COGT stock. They have purchased $0 and sold $0 worth of shares.
Cole Pinnow's most recent insider trade was on Dec 17, 2025, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $39.45 |
| Discretionary |
| Dec 17, 2025 | COGT | $0 | Award | 214,000 | $N/A | Discretionary |